SecBot SecBot

Advancing Research for Chronic Pain Act of 2026

S. 5041 Sen. Timothy Kaine (D-VA) In committee
  1. Introduced Jul 21
  2. Committee Jul 21
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 21, 2026Next: Senate vote
99d ago Jul 21, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Member trades
10trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill advances population research for chronic pain by amending the Public Health Service Act. It directs the Secretary of Health and Human Services to use federal data to clarify chronic pain incidence and prevalence, identify data gaps, and collect deidentified population research data using medical claims and surveys. The Secretary must also develop standard definitions and approaches for chronic pain research with experts and disseminate findings.

Sec. 2, National Chronic Pain Information System: The Secretary, consulting with CDC, NIH, and other agencies, must utilize federal research data to clarify chronic pain incidence and prevalence from any source, including injuries, operations, and diseases. They must identify data gaps and collect deidentified data on specific pain conditions, demographics, risk factors, diagnosis markers, costs, epidemiology, management, treatment, co-occurring conditions, service utilization, treatment effectiveness, and non-opioid approaches. The Secretary must develop standard definitions with experts including patients, epidemiologists, and clinicians, and disseminate findings via a public web page.

The Secretary, through CDC, must establish a public Chronic Pain Information Hub that aggregates federal data and research, summarizes CDC's data collection, and translates findings into clinical tools and annual recommendations for researchers.

Collaborators receiving payments from drug or device manufacturers must disclose such payments to the Secretary, who makes them public.

Within two years of enactment, the Secretary must report to Congress on the Hub's development, information made available, data gaps identified, feedback processes, and collaborator feedback.

Chronic pain is defined as persistent or recurrent pain lasting longer than 3 months.

Such sums as necessary are authorized for fiscal years 2026 through 2030.

Summary of the bill text as introduced in Senate (Jul 21, 2026), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.